Your doctor will weigh several critical factors to map out the best path forward
Additionally, hypoglycemia, although more likely in combination with other glucose-lowering medications, is a potential risk associated with overdose due to Semaglutides insulinotropic effects
In some cases, your provider might suggest a step-up approach, starting with a lower dose of Ozempic and gradually increasing to the full dosage
Quick answer: Yes, you can gain weight on semaglutide, and regain after stopping is common because the drugs appetite-suppressing effects wear off
Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
